Johannes Schueller
- Oncology top 5%
- Surgery
- Hepatology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Endocrine and Autonomic Systems top 10%
- Co-authors
- Dietmar TamandlThomas GruenbergerWerner ScheithauerChristoph ZielinskiFriedrich HerbstBirgit GruenbergerKlaus KaczirekR. Roka
- Topics
- Cancer Treatment and Pharmacology (8 papers)Colorectal Cancer Treatments and Studies (7 papers)Gastric Cancer Management and Outcomes (3 papers)
In The Last Decade
Johannes Schueller
11 papers receiving 746 citations
Peers
Comparison fields: 5 of 73
- Oncology 547
- Surgery 271
- Hepatology 246
- Pulmonary and Respiratory Medicine 232
- Endocrine and Autonomic Systems 106
Countries citing papers authored by Johannes Schueller
This map shows the geographic impact of Johannes Schueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Schueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Schueller more than expected).
Fields of papers citing papers by Johannes Schueller
This network shows the impact of papers produced by Johannes Schueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Schueller. The network helps show where Johannes Schueller may publish in the future.
Co-authorship network of co-authors of Johannes Schueller
This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Schueller. A scholar is included among the top collaborators of Johannes Schueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Schueller. Johannes Schueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumab. | 12 |
| 2 | 187 | |
| 3 | A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes. | 28 |
| 4 | Pharmacokinetics of irinotecan in combination with biweekly cetuximab in patients with advanced colorectal cancer. | 10 |
| 5 | 315 | |
| 6 | 11 | |
| 7 | 178 | |
| 8 | 5 | |
| 9 | Pharmacokinetics and metabolism of irinotecan combined with capecitabine in patients with advanced colorectal cancer. | 9 |
| 10 | 3 | |
| 11 | Clinical pharmacokinetics and metabolism of paclitaxel after polychemotherapy with the cytoprotective agent amifostine. | 5 |
About Johannes Schueller
Johannes Schueller is a scholar working on Oncology, Hepatology and Pharmacy, having authored 11 papers that have together received 763 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Hepatology (246 citations), Oncology (547 citations) and Endocrine and Autonomic Systems (106 citations). Johannes Schueller has collaborated with scholars based in Austria, Canada and France. Frequent co-authors include Dietmar Tamandl, Thomas Gruenberger, Werner Scheithauer, Christoph Zielinski, Friedrich Herbst, Birgit Gruenberger, Klaus Kaczirek, R. Roka, Fritz Wrba and Martin Czejka. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.